The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites

Journal of Immunology

Volumn 156, Issue 5, 1996, Pages 1937-1941

  Gadangi, Pratap ^a,b   Longaker, Michael ^a   Naime, Dwight ^a,b   Levin, Richard I ^a   Recht, Phoebe A ^a   Montesinos, M Carmen ^a,b   Buckley, Michael T ^a   Carlin, Gunnar ^c   Cronstein, Bruce N ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; MESALAZINE; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RHEUMATOID ARTHRITIS;

ACYLTRANSFERASES; ADENOSINE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYL AND FORMYL TRANSFERASES; MICE; MICE, INBRED BALB C; NEUTROPHIL ACTIVATION; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE; RIBONUCLEOTIDES; SULFASALAZINE;

EID: 0030026499     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Baggott, J. E , S. L Morgan, T. Ha, W H. Vaughn, and R. J. Hine. 1992 Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem. J. 282:197
2. Baggott, J. E., S. L Morgan, T. Ha, G S. Alarcon, W. J. Koopman, and C. L. Krumdieck 1993 Antifolates in rheumatoid arthritis, a hypothetical mechanism of action Clin. Exp. Rheumatol 11(Suppl 8):S101.
3. Cronstein, B. N , R I. Levin, J. Belanoff, G. Weissmann, and R. Hirschhorn. 1986. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells J. Clin. Invest. 78.760
4. Cronstein, B. N , R. I Levin, M. R Philips, R. Hirschhorn, S. B. Abramson, and G Weissmann 1992 Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol. 148. 2201.
5. Cronstein, B. N , M. A. Eberle, H E. Gruber, and R I. Levin. 1991 Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl Acad Sci. USA 88:2441.
6. Cronstein, B. N., D. Naime, and E Ostad. 1993. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation J. Clin Invest 92:2675.
7. Jaffe, E. A., R. L. Nachman, C G. Becker, and C. R Minick. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria J Clin Invest 52:2745.
8. Levin, R. I , D. A. Moscatelli, and P. A Recht. 1993. Oxalate, a potential atherogenic toxin of uremia, inhibits endothelial proliferation induced by heparin-binding growth factors in vitro J. Endothelial Res. 1:179.
9. Cronstein, B. N., S C. Kimmel, R I. Levin, F Martiniuk, and G. Weissmann. 1992 A mechanism for the antiinflammatory effects of corticosteroids the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of ELAM-1 and ICAM-1. Proc. Natl. Acad Sci USA 89.9991.
10. Zurier, R B., S. Hoffstein, and G Weissmann. 1973. Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins. Arthritis Rheum 16:606.
11. Cronstein, B N., S B Kramer, G. Weissmann, and R. Hirschhorn. 1983 Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158.1160.
12. Hirschhorn, R., V Roegner-Maniscalco, L. Kuritsky, and F S. Rosen. 1981. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J. Clin. Invest. 68:1387
13. Dixon, R., J. Fujitaki, L. Chrastil, and J. Lee. 1989. AICA-Riboside: direct quantitation in ultrafiltrates of plasma by HPLC during pharmacokinetic studies in man. Res. Commun Chem. Pathol. Pharmacol. 65:405
14. Clegg, D. O. 1993. Sulfasalazine. In Arthritis and Allied Conditions, 12th ed. D J. McCarty and W. J. Koopman, eds. Lea & Febiger, Philadelphia, p. 637.
15. Zheng, W., S. M Winter, M. Mayersohn, J. B. Bishop, and I. G. Sipes. 1993. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice. Drug Metabol Dispos. 21:1091.
16. Crossley, M. J., M. Spowage, and I. M. Hunneyball. 1987. Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice. Drugs Exp. Clin. Res 13:273.
17. Selhub, J., J. Dhar, and I. H. Rosenberg. 1978 Inhibition of folate enzymes by sulfasalazine. J. Clin. Invest. 61.221
18. Barankiewicz, J., G. Ronlov, R. Jimenez, and H. E Gruber. 1990 Selective adenosine release from human B but not T lymphoid cell line. J Biol. Chem. 265:15738
19. Barankiewicz, J., R. Jimenez, G. Ronlov, M. Magill, and H. E. Gruber. 1990 Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Arch Biochem. Biophys. 282 377.
20. Kitakaze, M., M. Hori, T. Monoka, S. Takashima, T. Minamino, H Sato, M. Inoue, and T. Kamada. 1993. Attenuation of ecto-5′-nucleotidase activity and adenosine release in activated human polymorphonuclear leukocytes Circ. Res. 73:524
21. Baggott, J E., W. H. Vaughn, and B B. Hudson. 1986. Inhibition of 5-amino-imidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem. J. 236:193.
22. Chabner, B. A., C. J. Allegra, G. A Curt, N. J. Clendeninn, J. Baram, S. Koizumi, J. C. Drake, and J. Jolivet. 1985. Polyglutamation of methotrexate, is methotrexate a prodrug? J. Clin. Invest. 76:907
23. Allegra, C J., J C. Drake, J. Jolivet, and B A. Chabner 1985. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc. Natl. Acad. Sci. USA 82:4881.
24. Firestein, G. S., D. A. Bullough, M. D. Erion, R. Jimenez, M. Ramirez-Weinhouse, J Barankiewicz, C. W. Smith, H E. Gruber, and K. M. Mullane. 1995. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins. J. Immunol 154:326.
25. Asako, H., P Kubes, B. Baethge, R. Wolf, and D N. Granger. 1992 Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules. Inflammation 16:45.
26. Asako, H., R. E Wolf, and D. N. Granger. 1993. Leukocyte adherence in rat mesenteric venules, effects of adenosine and methotrexate. Gastroenterology 104:31
27. Parmely, M. J., W.-W Zhou, C. K. Edwards, III, D R. Borcherding, R. Silverstein, and D. C Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol. 151:389.
28. Bouma, M. G , R K. Stad, F A. J. M. van den Wildenberg, and W. A. Buurman 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol 153:4159.
29. Tsai, V., G. S. Firestein, W. Arend, and N. J. Zvaifler. 1992. Cytokine-induced differentiation of cultured nonadherent macrophages. Cell Immunol. 144:203
30. Cronstein, B. N., D. Naime, and G. S Firestein. 1995. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine Arthritis Rheum 38:1040
31. Firestein, G S , D. Boyle, D A. Bullough, H. E. Gruber, F G. Sajjadi, A. Montag, B Sambol, and K. Mullane. 1994. Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol. 152.5853.
32. Rosengren, S., G. W. Bong, and G S. Firestein 1995. Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J Immunol 154:5444.
33. Boyle, D L., F. G Sajjadi, and G. S Firestein. 1995. Selective down regulation of collagenase expression by adenosine. Arthritis Rheum. 38 (Suppl ).S343 (Abstr.)
34. Firestein, G. S , M M. Paine, and D L Boyle 1994. Mechanisms of methotrexate action in rheumatoid arthritis, selective decrease in synovial collagenase gene expression. Arthritis Rheum. 37:193